All-cause mortality among self-reporting rapamycin users: an observational cohort

No mortality benefit observed in a small self-selected cohort. Severe confounders; underpowered.

• 01Design: Retrospective cohort — weighted accordingly in our rubric.
• 02Notable limitations — confounding, sample size, or short follow-up.
• 03Effect direction is consistent with adjacent literature in our index.

Native comments, Twitter mentions, and Reddit threads about this paper — surfaced together so the conversation isn't fragmented across platforms.